GCC19CART
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

GCC19CART Trademark

Serial Number: 97029671

GCC19CART is a trademark filed by Innovative Cellular Therapeutics Holdings, Ltd. on September 15, 2021. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Innovative Cellular Therapeutics Holdings, Ltd.

Rockville, MD 20850

Entity Type: 99

Trademark Details

Filing Date

September 15, 2021

Registration Date

Not Registered

Published for Opposition

April 18, 2023

Goods & Services

Stem cell therapy services; Immunotherapy services in the nature of medical services; collection and preservation of biological tissue, blood and cells; Medical diagnostic testing, monitoring, and reporting services; Medical treatment of of cancer such as colon carcinoma, lymphoid malignancy, pancreatic cancer, breast cancer, lung cancers, ovarian cancer, prostate cancer, and autoimmune diseases such as Systemic lupus erythematosus (SLE); Health care services, namely, providing a database in the field of cell therapy such as Chimeric Antigen Receptor therapy, TCR (T-Cell Receptor) therapy, TIL (tumor-infiltrating lymphocyte) therapy, Natural Killer (NK) cell therapy, and Stem Cell therapy, and gene therapy information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; providing medical information; services in the extraction of cells from patients in the nature of stem cell therapy services; manipulation of cells for therapeutic purposes in the nature of stem cell therapy services; reinsertion of cells into human patients in the nature of stem cell therapy services

Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations and drugs in the field of immunotherapy; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations and drugs in the field cell therapy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 1, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 1, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 30, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 29, 2024 EX2G
SOU EXTENSION 2 FILED
May 29, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 29, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 8, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 6, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 6, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 6, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 13, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 18, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 18, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 29, 2023 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 21, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 7, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 18, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 18, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 17, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2021 NWOS
NEW APPLICATION ENTERED
Sep 18, 2021 NWAP